Electromed (ELMD) Competitors $23.05 +0.02 (+0.09%) Closing price 04:00 PM EasternExtended Trading$22.96 -0.09 (-0.37%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock ELMD vs. AXGN, EMBC, IRMD, SIBN, BVS, RXST, BFLY, AVNS, CBLL, and KIDSShould you be buying Electromed stock or one of its competitors? The main competitors of Electromed include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), SI-BONE (SIBN), Bioventus (BVS), RxSight (RXST), Butterfly Network (BFLY), Avanos Medical (AVNS), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Electromed vs. AxoGen Embecta Iradimed SI-BONE Bioventus RxSight Butterfly Network Avanos Medical CeriBell OrthoPediatrics AxoGen (NASDAQ:AXGN) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Does the MarketBeat Community favor AXGN or ELMD? AxoGen received 434 more outperform votes than Electromed when rated by MarketBeat users. However, 92.00% of users gave Electromed an outperform vote while only 72.89% of users gave AxoGen an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45772.89% Underperform Votes17027.11% ElectromedOutperform Votes2392.00% Underperform Votes28.00% Do institutionals & insiders believe in AXGN or ELMD? 80.3% of AxoGen shares are held by institutional investors. Comparatively, 40.8% of Electromed shares are held by institutional investors. 7.0% of AxoGen shares are held by insiders. Comparatively, 14.0% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings & valuation, AXGN or ELMD? Electromed has lower revenue, but higher earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M3.90-$21.72M-$0.22-74.91Electromed$59.63M3.31$5.15M$0.7530.73 Is AXGN or ELMD more profitable? Electromed has a net margin of 11.34% compared to AxoGen's net margin of -7.91%. Electromed's return on equity of 15.71% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% Electromed 11.34%15.71%13.37% Which has more volatility and risk, AXGN or ELMD? AxoGen has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Electromed has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500. Do analysts rate AXGN or ELMD? AxoGen currently has a consensus price target of $22.60, indicating a potential upside of 37.14%. Electromed has a consensus price target of $38.00, indicating a potential upside of 64.86%. Given Electromed's stronger consensus rating and higher probable upside, analysts clearly believe Electromed is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Electromed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Does the media prefer AXGN or ELMD? In the previous week, AxoGen had 7 more articles in the media than Electromed. MarketBeat recorded 7 mentions for AxoGen and 0 mentions for Electromed. AxoGen's average media sentiment score of 1.33 beat Electromed's score of 0.00 indicating that AxoGen is being referred to more favorably in the media. Company Overall Sentiment AxoGen Positive Electromed Neutral SummaryElectromed beats AxoGen on 11 of the 19 factors compared between the two stocks. Get Electromed News Delivered to You Automatically Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELMD vs. The Competition Export to ExcelMetricElectromedElectromedical equipment IndustryMedical SectorNYSE ExchangeMarket Cap$197.24M$3.19B$5.48B$18.90BDividend YieldN/A1.80%5.11%4.02%P/E Ratio30.7315.5422.6032.86Price / Sales3.3155.52397.5527.89Price / Cash41.3644.0938.1817.52Price / Book4.523.546.744.47Net Income$5.15M$94.03M$3.22B$1.02B7 Day Performance-0.86%4.13%1.55%0.73%1 Month Performance-4.71%7.53%4.04%-2.62%1 Year Performance30.59%-17.55%15.63%4.59% Electromed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELMDElectromed0.618 of 5 stars$23.05+0.1%$38.00+64.9%+32.4%$197.24M$59.63M30.73160Analyst UpgradeAXGNAxoGen2.8984 of 5 stars$16.20-1.2%$22.60+39.5%+153.8%$718.42M$187.34M-50.63450Upcoming EarningsPositive NewsEMBCEmbecta4.5882 of 5 stars$12.36+4.0%$20.33+64.5%+20.3%$718.36M$1.11B12.361,900Upcoming EarningsPositive NewsIRMDIradimed4.8043 of 5 stars$53.19-0.3%$72.00+35.4%+29.1%$676.25M$73.24M35.46110Positive NewsSIBNSI-BONE4.1734 of 5 stars$14.48+0.5%$24.40+68.5%-4.3%$614.80M$167.18M-15.74350Upcoming EarningsNews CoveragePositive NewsBVSBioventus3.2697 of 5 stars$7.43-2.9%$15.00+101.9%+84.6%$608.93M$573.28M-12.181,200Positive NewsRXSTRxSight2.6454 of 5 stars$14.58-2.5%$37.60+158.0%-71.8%$592.04M$139.93M-17.56220Upcoming EarningsBFLYButterfly Network2.5525 of 5 stars$2.44-0.2%$3.00+23.2%+198.6%$591.52M$82.06M-5.29460Upcoming EarningsInsider TradeNews CoverageGap UpAVNSAvanos Medical2.1604 of 5 stars$12.69+2.7%N/A-30.6%$583.55M$687.80M37.314,040Short Interest ↑Analyst RevisionCBLLCeriBell2.2024 of 5 stars$16.23+6.0%$32.50+100.3%N/A$581.96M$65.44M0.00N/ANews CoverageKIDSOrthoPediatrics4.1396 of 5 stars$21.79+1.2%$37.00+69.8%-29.7%$529.21M$204.73M-17.72200Upcoming EarningsPositive News Related Companies and Tools Related Companies AXGN Competitors EMBC Competitors IRMD Competitors SIBN Competitors BVS Competitors RXST Competitors BFLY Competitors AVNS Competitors CBLL Competitors KIDS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELMD) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Electromed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Electromed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ELMD Stock Free ELMD Stock Alerts